Toumaz Holdings, the AIM-listed investment company focused on the technology sector, has upped its stake in Sentinel Healthcare Solutions, a developer of intelligent healthcare services, to 81.25 per cent.  

Toumaz Holdings, the AIM-listed investment company focused on the technology sector, has upped its stake in Sentinel Healthcare Solutions, a developer of intelligent healthcare services, to 81.25 per cent.  

The financial details of the transaction have not been revealed but the additional 31.25 per cent interest was acquired from Continum Group for “very favourable terms”, the company said.

The deal was driven by Sentinel’s MyAmego telecare technology, which monitors dementia sufferers with a bracelet or necklace, capturing data through monitors installed in care homes.

Last year, MyAmego won its first commercial contract in a new purpose-built local authority care home in Scotland. Steered by CEO Guy Spelman, Toumaz has plans to develop and commercialise MyAmego in further care homes.

He commented: “MyAmego demonstrated positive progress in 2008 in entering the dementia care market by rapidly gaining widespread recognition of its unique qualities. We believe that our increased interest in Sentinel will enable us to speed up the commercial prospects of MyAmego in the UK care home market, particularly in relation to dementia carers, while at the same time keeping operational costs low.”

In July, Toumaz reported that it had cut its pre-tax losses from £2.68 million to £1.75 million on a like-for-like basis.